• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • COVID-19

    In Brief: Zipline announces COVID-19 vaccine drone delivery plans

    Drone company Zipline announces that it is building an end-to-end cold chain distribution capability to distribute COVID-19 vaccines in each of the countries where it operates.

    By Catherine Cheney // 04 February 2021
    Zipline flight operators perform pre-flight checks on a drone in Accra, Ghana. Photo by: Zipline / Handout via Reuters

    Zipline, a company that delivers blood, vaccines, and other medical equipment using its fleet of unmanned aerial vehicles, is building an end-to-end cold chain distribution capability to distribute COVID-19 vaccines in Rwanda, Ghana, Nigeria, and rural and remote parts of the United States, the company said Thursday.

    This will enable the drone delivery service to deliver all leading COVID-19 vaccines at their required temperatures, in precise quantities, and on demand.

    Why it matters: Vaccines that require ultra-low temperature ranges, such as Pfizer’s COVID-19 vaccine, require dry ice or highly specialized freezers, posing challenges to plans to transport, store, and distribute doses to hard-to-reach places.

    Remote technologies find a role in COVID-19 response

    Movement restrictions are isolating health workers and disrupting supply chains. So organizations are turning to drones, video chatting, mobile applications, and other tech solutions for help.

    Zipline, which launched in Rwanda in 2016 and announced an expansion to Nigeria this week, ships cold-chain dependent vaccines in the standard and frozen ranges daily and has delivered more than 1 million routine vaccines to date. It also has some experience shipping products at ultra-low temperature ranges, which is more difficult.

    “Where you live shouldn’t determine whether or not you get a COVID-19 vaccine,” Zipline CEO Keller Rinaudo said in a press release. “We can help health systems bypass infrastructure and supply challenges through instant delivery.”

    Who’s behind it: Zipline says this initiative is a collaboration with an unnamed “leading manufacturer of COVID-19 vaccines.” The partnership builds on Zipline’s work with Gavi, the Vaccine Alliance.

    What’s next: Zipline will add ultra-low refrigeration capacity at its distribution centers and conduct end-to-end thermal validation to ensure vaccines remain within their required temperature ranges. The company expects to be ready to deliver COVID-19 vaccines to the areas where it operates in April.

    • Innovation & ICT
    • Global Health
    • Private Sector
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Catherine Cheney

      Catherine Cheneycatherinecheney

      Catherine Cheney is the Senior Editor for Special Coverage at Devex. She leads the editorial vision of Devex’s news events and editorial coverage of key moments on the global development calendar. Catherine joined Devex as a reporter, focusing on technology and innovation in making progress on the Sustainable Development Goals. Prior to joining Devex, Catherine earned her bachelor’s and master’s degrees from Yale University, and worked as a web producer for POLITICO, a reporter for World Politics Review, and special projects editor at NationSwell. She has reported domestically and internationally for outlets including The Atlantic and the Washington Post. Catherine also works for the Solutions Journalism Network, a non profit organization that supports journalists and news organizations to report on responses to problems.

    Search for articles

    Most Read

    • 1
      Opinion: How climate philanthropy can solve its innovation challenge
    • 2
      The legal case threatening to upend philanthropy's DEI efforts
    • 3
      Closing the loop: Transforming waste into valuable resources
    • 4
      Why most of the UK's aid budget rise cannot be spent on frontline aid
    • 5
      How is China's foreign aid changing?
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement